Can Lymphocytosis Detected in Bronchoalveolar Lavage Serve as a Prognostic Indicator?

Overview

This study investigates the prognostic value of bronchoalveolar lavage (BAL) lymphocytosis in fibrotic hypersensitivity pneumonitis (fHP) patients, particularly in those receiving immunomodulatory therapy.

Background

Fibrotic hypersensitivity pneumonitis (fHP) presents a variable clinical course, making prognostic indicators crucial for patient management. BAL lymphocytosis is a recognized diagnostic feature of fHP, but its prognostic implications, especially under immunomodulatory treatment, remain unclear.

Data Highlights

Key Findings

• BAL lymphocytosis was associated with less severe disease in both untreated and treated fHP patients.
• Higher BAL lymphocyte percentages correlated with more favorable changes in the composite physiologic index (CPI).
• In untreated patients, a 10% increase in BAL lymphocytes predicted a 1.7-point improvement in CPI (p < 0.0001).
• In treated patients, a similar increase predicted a 2.0-point improvement in CPI (p < 0.0001).
• Higher BAL lymphocyte percentages independently predicted lower mortality in both groups.
• No significant interaction was found between treatment status and BAL lymphocyte levels regarding outcomes.

Clinical Implications

The findings indicate that BAL lymphocytosis may have prognostic value in fHP patients.

Conclusion

BAL lymphocytosis is associated with less severe disease and favorable outcomes in fHP patients.

Related Resources & Content

1. Author(s)/Org, Source, Year -- Title
2. Author(s)/Org, Source, Year -- Title
3. Author(s)/Org, Source, Year -- Title
4. The ASCO Post — Tumor Immune Infiltration and Disease Progression in Follicular Lymphoma
5. Bone Marrow Transplantation — Interstitial Lung Disorders Following Hematopoietic Stem Cell Transplantation: A Novel Presentation of Chronic Graft-Versus-Host Disease?
6. Bone Marrow Transplantation — Understanding the Known and Unknown Aspects of Bronchiolitis Obliterans Syndrome
7. Frontiers in Immunology — Lactate dehydrogenase-to-albumin ratio as a potential prognostic indicator in glucocorticoid-treated severe pneumonia: a multicenter retrospective study with external validation
8. Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline
9. Impact of Lymphocytosis in Bronchoalveolar Lavage Fluid on Corticosteroid Treatment in Fibrotic Hypersensitivity Pneumonitis
10. BAL cells analysis and lung function parameters in fibrotic hypersensitivity pneumonitis at baseline and in relation to survival - ScienceDirect
11. Clinical predictors of physiologic change after treatment with immunosuppression in hypersensitivity pneumonitis | PLOS One
12. Mycophenolate and Azathioprine in Fibrotic Interstitial Lung Disease - PubMed
13. Nintedanib in Progressive Fibrosing Interstitial Lung Diseases | New England Journal of Medicine
14. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline - PMC
15. Diagnosis and management of hypersensitivity pneumonitis in adults: A position statement from the Thoracic Society of Australia and New Zealand - Barnes - 2024 - Respirology - Wiley Online Library
16. Update of the international multidisciplinary classification of the interstitial pneumonias: an ERS/ATS statement | European Respiratory Society